Identity
- Trade Name
- 03 Sensor rS02 Large Adhesive Sensor FDA UDI
- Generic Name
- Tissue saturation oximeter sensor, single-use FDA UDI
- Model / Reference
- 3756 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 10843997008416 FDA UDI
- FDA Product Code
- MUD FDA UDI
- GMDN Term
- Tissue saturation oximeter sensor, single-use FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 870.2700 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Tissue saturation oximeter sensor, single-use
03 Sensor rS02 Large Adhesive Sensor by Masimo Corporation — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Tissue saturation oximeter sensor, single-use.
- ForeSight — Edwards Lifesciences LLC · Class II
- ForeSight — Edwards Lifesciences LLC · Class II
- FORE-SIGHT® — Cas Medical Systems, Inc. · Class II
- FORE-SIGHT ELITE® — Cas Medical Systems, Inc. · Class II
- Spectros T-Stat — Spectros Corporation · Class II
- ForeSight — Edwards Lifesciences LLC · Class II
- FORE-SIGHT ELITE® — Cas Medical Systems, Inc. · Class II
- Intra.Ox Smart Sensor — VIOPTIX, INC. · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Masimo Corporation
Sources (1)
- FDA UDI 4c3c4059-5505-42ca-9ab7-270b89139e55 33 fields · synced Jun 8, 2026